Fulcrum Therapeutics, Inc. · NASDAQ:FULC

BlackRock, Inc. reported a 7.50% stake in Fulcrum Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 17, 2025

BlackRock, Inc. reported a 7.50% stake in Fulcrum Therapeutics, Inc., 4,032,876 shares, as a passive investor on Mar 31, 2025. Filed Apr 17, 2025 (Schedule 13G/A).

Stake
7.50%
Shares
4,032,876
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.7.50%4,032,876

Source

View original at SEC

Related